Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03052205
Title A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Acronym ILLUMINATE-101
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idera Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale Arizona 85258 United States Details
The University of Arizona Cancer Center Tucson Arizona 85724 United States Details
University of California San Francisco (UCSF) San Francisco California 94143 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
The Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
St. Luke's Hospital Easton Pennsylvania 18045 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Rambam Medical Center Haifa 3109601 Israel Details
Hadassah Medical Center Jerusalem 9112001 Israel Details
Rabin Medical Center Beilinson Campus Petah tikva 49100 Israel Details
The Ella Lemelbaum Institute for Immuno-Oncology Ramat Gan 5265601 Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field